Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northrop Grumman Corporation (NOC) vs TransMedics Group Inc (TMDX) Price & Performance

Northrop Grumman CorporationTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Northrop Grumman Corporation vs TransMedics Group Inc — how do they compare? Northrop Grumman Corporation trades at $513.77 (market cap $74.42B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Northrop Grumman Corporation is far larger — about 29.3× TransMedics Group Inc's market cap, and Northrop Grumman Corporation pays a 1.79% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

NOCTMDX
Market Cap
$74.42B$2.54B
Sector
IndustrialsTechnology
52-Week High
$768.02$150.42
52-Week Low
$496.02$61.99
Enterprise Value
$88.65B$2.94B
Dividend Yield
1.79%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX